Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Exploring Three High Growth Tech Stocks In Hong Kong

In This Article:

As global markets experience fluctuations, with Chinese equities recently declining and the Hang Seng Index falling significantly, investors are keenly observing how Hong Kong's tech sector might respond amidst these dynamics. In this environment, identifying high-growth tech stocks can involve looking for companies that demonstrate resilience and innovation in the face of economic challenges, offering potential opportunities for growth despite broader market sentiment.

Top 10 High Growth Tech Companies In Hong Kong

Name

Revenue Growth

Earnings Growth

Growth Rating

Wasion Holdings

22.37%

25.47%

★★★★★☆

MedSci Healthcare Holdings

48.74%

48.78%

★★★★★☆

Inspur Digital Enterprise Technology

25.31%

39.04%

★★★★★☆

RemeGen

26.30%

52.19%

★★★★★☆

Innovent Biologics

21.80%

59.60%

★★★★★☆

Akeso

33.44%

53.00%

★★★★★★

Cowell e Holdings

31.68%

35.44%

★★★★★★

Biocytogen Pharmaceuticals (Beijing)

21.53%

109.17%

★★★★★☆

Beijing Airdoc Technology

37.47%

93.35%

★★★★★☆

Sichuan Kelun-Biotech Biopharmaceutical

24.70%

8.53%

★★★★★☆

Click here to see the full list of 43 stocks from our SEHK High Growth Tech and AI Stocks screener.

Let's uncover some gems from our specialized screener.

Cowell e Holdings

Simply Wall St Growth Rating: ★★★★★★

Overview: Cowell e Holdings Inc. is an investment holding company that designs, develops, manufactures, trades in, and sells optical modules and systems integration products for smartphones, multimedia tablets, smart driving, and other mobile devices across various international markets with a market cap of approximately HK$20.22 billion.

Operations: Cowell e Holdings generates revenue primarily from its photographic equipment and supplies segment, amounting to $1.14 billion. The company operates in the People’s Republic of China, India, the Republic of Korea, and other international markets.

Cowell e Holdings, amidst a challenging landscape, demonstrated resilience with a significant sales increase to USD 585.93 million from USD 366.73 million year-over-year. Despite this growth, net income slightly decreased to USD 16.04 million from USD 18.03 million, reflecting a complex operational environment but underscoring the company's capacity to generate revenue under pressure. Notably, the firm is positioned for robust future growth with expected annual revenue and earnings expansions at rates of 31.7% and 35.4%, respectively—outpacing broader Hong Kong market projections significantly. These figures suggest strategic R&D investments are likely underway to foster innovation and maintain competitive advantage in its sector.